In addition, Parkin/PINK1 levels are altered in PBMCs of patients with type 2 diabetes, and mitophagy is reversed in PBMCs of patients treated with metformin (Marañón et al. 2022). Here, PRKN is linked to type 2 diabetes mellitus.